Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-21-020253

General Counsel and Secretary gave up 1,353 shares (to pay taxes)

  • General Counsel and Secretary acquired 2,833 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KASINGER JAMES R. General Counsel and Secretary 2021-03-10 Option exercise +2,833 25,264 D
KASINGER JAMES R. General Counsel and Secretary 2021-03-10 Shares withheld for taxes −1,353 $124.15 $167,975 23,911 D
Derivatives
KASINGER JAMES R. General Counsel and Secretary 2021-03-11 Grant or award · Stock Option (Right to Buy) +25,360 25,360 D
KASINGER JAMES R. General Counsel and Secretary 2021-03-11 Grant or award · Restricted Stock Units +9,000 9,000 D
Loading xslF345X03/doc4.xml…